Analyst Coverage Initiated Stock
Report Date: 06-15-2022
Symbol: TNYA - Tenaya Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Analyst Coverage Initiated: TNYA rating Buy by H.C. Wainwright
Price Target: $25
Tenaya Therapeutics, Inc. (TNYA)
171 Oyster Point Boulevard
South San Francisco, CA
Phone: 760 310 9976
Website: http://www.tenayatherapeutics.com
CEO:
Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a payload to cardiac fibroblasts; and precision medicine platform, which provides personalized medicine approach to treat heart disease. The company was incorporated in 2016 and is based in South San Francisco, California.